Rocket Pharmaceuticals Investor Relations Material
Latest events
Study Update
Rocket Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Rocket Pharmaceuticals Inc
Access all reports
Rocket Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing gene therapies for rare and life-threatening genetic diseases. The company’s pipeline includes gene therapy programs targeting both hematologic and cardiovascular disorders. Rocket Pharmaceuticals uses lentiviral and adeno-associated virus (AAV) vectors to deliver corrective genes to patients' cells, aiming to provide long-term, potentially curative treatments. Its therapies are designed to address the underlying genetic causes of diseases, with a focus on disorders with limited treatment options. The company is headquartered in Cranbury, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Rocket Pharmaceuticals Inc
Corporate Presentation
Rocket Pharmaceuticals Inc
Corporate Presentation
Rocket Pharmaceuticals Inc
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
RCKT
Country
🇺🇸 United States